An analysis of the records of UK patients who had experienced a stroke has found that over half of those who should get drugs to prevent strokes were not prescribed them.
Nov 15, 2016
0
0
A blood thinning agent is helping researchers at the University of East Anglia understand more about the body's natural barriers to HIV.
Mar 23, 2015
0
14
(HealthDay)—Patients' preferences for outcomes of anticoagulation therapy vary and are affected by previous stroke or myocardial infarction experience, according to a study published online Nov. 11 in Circulation: Cardiovascular ...
Nov 12, 2014
0
0
Low dose aspirin lowers the occurrence of new venous blood clots – and represents a reasonable treatment option for patients who are not candidates for long-term anticoagulant drugs, such as warfarin, according to a new ...
Aug 25, 2014
0
0
New oral anticoagulant drugs that treat and prevent clots offer a much-needed alternative to warfarin, which has been used for more than 6 decades and has serious shortcomings. A new article published in BJS (British Journal ...
Apr 29, 2014
0
0
One-quarter of high risk patients do not receive anticoagulants after ablation of atrial fibrillation (AF), according to the latest survey of European practice.
Feb 18, 2014
0
0
(HealthDay)—The expanding scope of pharmacists' practice will potentially improve patient care but has implications for physicians, according to an article published online Aug. 19 in CMAJ, the journal of the Canadian Medical ...
Aug 20, 2013
0
0
Prothrombin complex concentrates (PCCs) are faster and more effective than fresh frozen plasma at reversing hemorrhage caused by the anti-coagulant warfarin, despite plasma being the most commonly used therapy. A literature ...
Aug 2, 2013
0
0
A new spin-out company from the University of Cambridge and Addenbrooke's Hospital, XO1 Ltd, has raised $11 million in funding to develop a new anticoagulant drug which has the potential to save millions of lives by preventing ...
Jun 17, 2013
0
0
(HealthDay)—Kcentra (prothrombin complex concentrate, human) has been approved by the U.S. Food and Drug Administration to treat severe acute bleeding in adults after administration of the anti-clotting drug warfarin and ...
Apr 30, 2013
0
0
